« Biomagnetics To Hold Investor Conference Call To Introduce World Class Biosensor Technology For Malaria, HIV And Tuberculosis Diagnosis | Home | HIV Vaccine Trial Results — An Opening for Further Research »
You must be logged in to post a comment.
Background The development of a safe and effective vaccine against the human immunodeficiency virus type 1 (HIV-1) is critical to pandemic control.
Methods In a community-based, randomized, multicenter, double-blind, placebo-controlled ...
« Sen. Grassley Prods Med Schools About Medical Journal Ghostwriting Practices | Home | 62-Year-Old Man Becomes First Patient In China Implanted With Rechargeable Neurostimulator For Chronic Pain »
You must be logged in to post a comment.
Background The development of a safe and effective vaccine against the human immunodeficiency virus type 1 (HIV-1) is critical to pandemic control.
Methods In a community-based, randomized, multicenter, double-blind, placebo-controlled ...
« QuantRx Debuts Flagship Diagnostic Reader Device (Q-Reader™) At MEDICA 2009, The World’s Leading Medical Trade Fair | Home | Cook Medical Drives Industry Innovation At 23rd Congress Of The Japanese Society Of Endourology And ESWL »
You must be logged in to post a comment.
Background The development of a safe and effective vaccine against the human immunodeficiency virus type 1 (HIV-1) is critical to pandemic control.
Methods In a community-based, randomized, multicenter, double-blind, placebo-controlled ...
« Increasing The Quality Of Our Second Half-Century: 50 Active Years After 50 | Home | Combined Immunodeficiency Associated with DOCK8 Mutations »
You must be logged in to post a comment.